Melanie Dannemeyer

Associate Director, Biopharma Drug Substance at AstraZeneca

Speaker

Melanie Dannemeyer is Associate Director of Tech Transfer at AstraZeneca, leading drug substance development, transfer, and manufacturing across vaccines, recombinant proteins, antibodies, bispecific, ADCs, and allogeneic cell therapies. She oversees integrated tech transfers and CMO/CDMO partnerships and previously held roles in Discovery Science, Process Development, and Manufacturing. She holds a Ph.D. in biophysics (University of Göttingen) and an M.Sc. in Genome Based Systems Biology and a B.Sc. in Molecular Biotechnology (Bielefeld University).